These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1545941)
1. Trial of Sinemet CR4 in patients with Parkinson's disease. Anderson TJ; Ewer TC; Gilchrist NL; Donaldson IM N Z Med J; 1992 Mar; 105(929):81-2. PubMed ID: 1545941 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations. Jankovic J; Schwartz K; Vander Linden C Mov Disord; 1989; 4(4):303-9. PubMed ID: 2682215 [TBL] [Abstract][Full Text] [Related]
4. Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease. Hutton JT; Morris JL; Bush DF; Smith ME; Liss CL; Reines S Neurology; 1989 Nov; 39(11 Suppl 2):67-72; discussion 72-3. PubMed ID: 2685652 [TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of controlled-release carbidopa/levodopa in patients with advanced Parkinson's disease. Mark MH; Sage JI Ann Clin Lab Sci; 1989; 19(6):415-21. PubMed ID: 2690730 [TBL] [Abstract][Full Text] [Related]
6. Controlled release levodopa/carbidopa (Sinemet CR4) in Parkinson's disease--an open evaluation of efficacy and safety. Bulling MT; Wing LM; Burns RJ Aust N Z J Med; 1991 Aug; 21(4):397-400. PubMed ID: 1953526 [TBL] [Abstract][Full Text] [Related]
7. Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa. Aarli JA; Gilhus NE Neurology; 1989 Nov; 39(11 Suppl 2):82-5; discussion 95. PubMed ID: 2586767 [TBL] [Abstract][Full Text] [Related]
8. Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa. Goetz CG; Tanner CM; Gilley DW; Klawans HL Neurology; 1989 Nov; 39(11 Suppl 2):63-6; discussion 72-3. PubMed ID: 2586764 [TBL] [Abstract][Full Text] [Related]
9. Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Goetz CG; Tanner CM; Shannon KM; Carroll VS; Klawans HL; Carvey PM; Gilley D Neurology; 1988 Jul; 38(7):1143-6. PubMed ID: 3290706 [TBL] [Abstract][Full Text] [Related]
11. Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease. Mark MH; Sage JI Ann Clin Lab Sci; 1989; 19(2):101-6. PubMed ID: 2665626 [TBL] [Abstract][Full Text] [Related]
12. An open multicenter long-term treatment evaluation of Sinemet CR. Sinemet CR Multicenter Study Group. Bush DF; Liss CL; Morton A Neurology; 1989 Nov; 39(11 Suppl 2):101-4; discussion 105. PubMed ID: 2685646 [TBL] [Abstract][Full Text] [Related]
13. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of standard Sinemet and Sinemet CR in patients with mild-to-moderate Parkinson's disease. Feldman RG; Mosbach PA; Kelly MR; Thomas CA; Saint Hilaire MH Neurology; 1989 Nov; 39(11 Suppl 2):96-101; discussion 105. PubMed ID: 2685655 [TBL] [Abstract][Full Text] [Related]
16. Sinemet CR in Parkinson's disease. Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878 [TBL] [Abstract][Full Text] [Related]
17. Sinemet (CR4): an open-label study in moderately severe Parkinson's disease. Ming A; Temlett JA; Fritz VU J Intern Med; 1991 Aug; 230(2):113-7. PubMed ID: 1865161 [TBL] [Abstract][Full Text] [Related]
18. The use of Sinemet CR in the management of mild to moderate Parkinson's disease. Rodnitzky RL Neurology; 1992 Jan; 42(1 Suppl 1):44-50; discussion 57-60. PubMed ID: 1549201 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease. Factor SA; Sanchez-Ramos JR; Weiner WJ; Ingenito AM J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):83-8. PubMed ID: 2709040 [TBL] [Abstract][Full Text] [Related]